How David Baltimore overturned the central dogma of biology and reshaped modern medicine

How David Baltimore overturned the central dogma of biology and reshaped modern medicine
Image: Intellect (generated)

In short: In 1970, David Baltimore discovered reverse transcriptase, an enzyme that allows genetic information to flow from RNA back to DNA. This breakthrough shattered the prevailing view that biological information moved only in one direction, fundamentally altering our understanding of viruses like HIV and opening new frontiers in cancer research.

David Baltimore’s career began with a rapid ascent in molecular biology. After completing his PhD in just two years, he made foundational discoveries regarding virus replication. His most famous contribution, the discovery of reverse transcriptase, proved that retroviruses use an RNA template to synthesize DNA. This finding challenged the 'central dogma' of molecular biology, which previously held that genetic information flowed strictly from DNA to RNA to proteins. This discovery, shared with Howard Temin and Renato Dulbecco, earned them the 1975 Nobel Prize in Physiology or Medicine.

Beyond his laboratory research, Baltimore was a pivotal figure in science policy and institutional leadership. In 1975, he helped organize the Asilomar Conference on Recombinant DNA, which established safety guidelines for emerging biotechnology. He later founded the Whitehead Institute for Biomedical Research in 1982, creating a unique, self-governed model for academic research that became a global standard. His leadership extended to the presidency of Rockefeller University and later the California Institute of Technology, where he served from 1997 to 2005.

Baltimore’s influence also reached into clinical applications and public health. He was an early advocate for federal AIDS research funding, co-authoring a 1986 report that called for a $1 billion national strategy. His lab’s work on gene therapy and immunology—including the discovery of the transcription factor NF-κB and the identification of RAG-1 and RAG-2 proteins—provided the mechanisms for understanding immune specificity and cancer development. By the time his laboratory closed in 2018, Baltimore had held nearly 100 biotechnology patents, cementing his legacy as a central architect of modern molecular medicine.

Opens the Intellect+ feed with this card first. Swipe up for the next one.

Sources

To cite this card, link to https://intellectplus.co.uk/app/science-david-baltimore.

How we source, check and correct cards: Editorial standards.

General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.

Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?

Related

Finding something worth knowing…